Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Müller, M; Schönfeld, CL; Grammer, T; Krane, V; Drechsler, C; Genser, B; Kohnen, T; Wanner, C; März, W.
Risk factors for retinopathy in hemodialysis patients with type 2 diabetes mellitus.
Sci Rep. 2020; 10(1):14158-14158
Doi: 10.1038/s41598-020-70998-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- März Winfried
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- There is limited knowledge on the prevalence and risk factors of diabetic retinopathy (DR) in dialysis patients. We have investigated the association between diabetes mellitus and lipid-related biomarkers and retinopathy in hemodialysis patients. We reviewed 1,255 hemodialysis patients with type 2 diabetes mellitus (T2DM) who participated in the German Diabetes and Dialysis Study (4D Study). Associations between categorical clinical, biochemical variables and diabetic retinopathy were examined by logistic regression. On average, patients were 66 ± 8 years of age, 54% were male and the HbA1c was 6.7% ± 1.3%. DR, found in 71% of the patients, was significantly and positively associated with fasting glucose, HbA1c, time on dialysis, age, systolic blood pressure, body mass index and the prevalence of other microvascular diseases (e.g. neuropathy). Unexpectedly, DR was associated with high HDL cholesterol and high apolipoproteins AI and AII. Patients with coronary artery disease were less likely to have DR. DR was not associated with gender, smoking, diastolic blood pressure, VLDL cholesterol, triglycerides, and LDL cholesterol. In summary, the prevalence of DR in patients with type 2 diabetes mellitus requiring hemodialysis is higher than in patients suffering from T2DM, who do not receive hemodialysis. DR was positively related to systolic blood pressure (BP), glucometabolic control, and, paradoxically, HDL cholesterol. This data suggests that glucose and blood pressure control may delay the development of DR in patients with diabetes mellitus on dialysis.
- Find related publications in this database (using NLM MeSH Indexing)
- Aged -
- Aged, 80 and over -
- Apolipoproteins - blood
- Blindness - epidemiology
- Blindness - etiology
- Blood Glucose - analysis
- Body Mass Index -
- Comorbidity -
- Coronary Disease - epidemiology
- Cross-Sectional Studies -
- Diabetes Mellitus, Type 2 - blood
- Diabetes Mellitus, Type 2 - complications
- Diabetic Nephropathies - epidemiology
- Diabetic Nephropathies - etiology
- Diabetic Retinopathy - epidemiology
- Diabetic Retinopathy - etiology
- Female -
- Glycated Hemoglobin A - analysis
- Humans -
- Hyperlipidemias - epidemiology
- Hypertension - epidemiology
- Inflammation - epidemiology
- Lipids - blood
- Male -
- Middle Aged -
- Prevalence -
- Renal Dialysis -
- Risk Factors -
- Smoking - epidemiology